Zailong Wang - Concepedia

Author

Zailong Wang

Novartis (United States)

Also Known As

Zailong Wang

Publications

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Novartis (Switzerland)AbbVie (United States)Cancer Genetics (United States)University of Glasgow

About

Zailong Wang is an author at Novartis (United States) specializing in medicine, clinical trials, and rheumatic diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	81
2	Obstetrics	1	1	69
3	Pathology	1	1	69
4	Rheumatology	1	1	12
5	Cancer Cell Biology	1	1	69

Zailong Wang

Publications

893

Citations

H-Index

Page 1

	Year	Citations
Prognostic DNA Methylation Biomarkers in Ovarian Cancer Susan Wei, Curtis Balch, Henry Paik, Clinical Cancer Research	2006	155
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial Lars Erik Kristensen, Mauro Waldemar Keiserman, Kim Papp, Annals of the Rheumatic Diseases	2021	135
Randomized Trial of Everolimus-Facilitated Calcineurin Inhibitor Minimization Over 24 Months in Renal Transplantation Diane M. Cibrik, Hélio Tedesco‐Silva, Anantharaman Vathsala, Transplantation	2013	103
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial Andrew J.K. Östör, Filip Van den Bosch, Kim Papp, Annals of the Rheumatic Diseases	2021	100
Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease, The Journal of Rheumatology	2016	87
Secukinumab for Long‐Term Treatment of Psoriatic Arthritis: A Two‐Year Followup From a Phase III, Randomized, Double‐Blind Placebo‐Controlled Study Arthur Kavanaugh, Philip J. Mease, Andreas Reimold, Arthritis Care & Research	2016	87
Hypermethylation of 18S and 28S Ribosomal DNAs Predicts Progression-Free Survival in Patients with Ovarian Cancer Michael W.Y. Chan, Susan Wei, Ping Wen, Clinical Cancer Research Epigenetic ChangePathologyGynecologyEpigeneticsTumor Biology	2005	69
Quantitative Proteomic Analyses of Molecular Mechanisms Associated with Cytoplasmic Incompatibility in <i>Drosophila melanogaster</i> Induced by <i>Wolbachia</i> Lin-Ling Yuan, Xiulan Chen, Qiong Zong, Journal of Proteome Research	2015	46
Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine Fuad S. Shihab, Diane M. Cibrik, Laurence Chan, Clinical Transplantation	2012	41
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study Andrew J.K. Östör, Filip Van den Bosch, Kim Papp, Lara D. Veeken	2022	27

Page 1